The clinical significance of hyperthermic intraperitoneal chemotherapy combined with PD-1 inhibitor and systemic chemotherapy for advanced gastric cancer patients with peritoneal metastasis: a single-center retrospective study
HIPEC combined with PD-1 inhibitor and systemic chemotherapy demonstrated encouraging survival and ascites control with an acceptable safety profile in GC patients with PM.
Authors
- Jiaqi Xie (ORCID: https://orcid.org/0000-0002-7309-3100)
- Xiaoyan Yang (ORCID: https://orcid.org/0000-0002-7591-7505)
- Y. wang
- Naiqing Ding
- Jiayi Liu (ORCID: https://orcid.org/0000-0003-1819-2998)
- Meijin Ren
- Y. Yang
- Ziyue Xiang
- Shanping Li
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fonc.2025.1728724
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00